Chemoinformaics analysis of (E)-1-Propenyl 2-propenyl disulfide
| Molecular Weight | 146.28 | nRot | 4 |
| Heavy Atom Molecular Weight | 136.2 | nRig | 16 |
| Exact Molecular Weight | 146.022 | nRing | 0 |
| Solubility: LogS | -7.059 | nHRing | 0 |
| Solubility: LogP | 6.015 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 22.4879 |
| nHD | 0 | BPOL | 12.4921 |
| QED | 0.493 |
| Synth | 1.783 |
| Natural Product Likeliness | -0.17 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.431 |
| Pgp-sub | 0.078 |
| HIA | 0.006 |
| CACO-2 | -4.711 |
| MDCK | 0.0000132 |
| BBB | 0.415 |
| PPB | 0.982908 |
| VDSS | 1.68 |
| FU | 0.00934032 |
| CYP1A2-inh | 0.919 |
| CYP1A2-sub | 0.641 |
| CYP2c19-inh | 0.611 |
| CYP2c19-sub | 0.334 |
| CYP2c9-inh | 0.468 |
| CYP2c9-sub | 0.873 |
| CYP2d6-inh | 0.774 |
| CYP2d6-sub | 0.927 |
| CYP3a4-inh | 0.391 |
| CYP3a4-sub | 0.375 |
| CL | 5.519 |
| T12 | 0.056 |
| hERG | 0.082 |
| Ames | 0.867 |
| ROA | 0.193 |
| SkinSen | 0.893 |
| Carcinogencity | 0.844 |
| EI | 0.995 |
| Respiratory | 0.086 |
| NR-Aromatase | 0.037 |
| Antiviral | No |
| Prediction | 0.945276 |